Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KIR Donor Selection: Feasibility in Identifying better Donors.
Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman S, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, Sobecks R, Parham P, Guethlein LA, Marsh SGE, Miller J; participating center writing committee. Weisdorf D, et al. Among authors: ross m. Biol Blood Marrow Transplant. 2019 Jan;25(1):e28-e32. doi: 10.1016/j.bbmt.2018.08.022. Epub 2018 Aug 24. Biol Blood Marrow Transplant. 2019. PMID: 30149149 Free PMC article. Clinical Trial.
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.
Chen GL, Liu H, Zhang Y, Thomas J, Ross M, Wang ES, Block AW, Sait S, Deeb G, Wallace P, Wetzler M, Hahn T, McCarthy PL. Chen GL, et al. Among authors: ross m. Biol Blood Marrow Transplant. 2014 Sep;20(9):1369-74. doi: 10.1016/j.bbmt.2014.05.013. Epub 2014 May 24. Biol Blood Marrow Transplant. 2014. PMID: 24867777 Free PMC article.
Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.
Hahn T, Paplham P, Austin-Ketch T, Zhang Y, Grimmer J, Burns M, Balderman S, Ross M, McCarthy PL. Hahn T, et al. Among authors: ross m. Biol Blood Marrow Transplant. 2017 Nov;23(11):1968-1973. doi: 10.1016/j.bbmt.2017.07.024. Epub 2017 Aug 4. Biol Blood Marrow Transplant. 2017. PMID: 28782599 Free article.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Chen GL, Carpenter PA, Broady R, Gregory TK, Johnston LJ, Storer BE, Beumer JH, Qiu J, Cerda K, Le R, Otani JM, Liu H, Ross MA, Arai S, Flowers MED, McCarthy PL, Miklos DB. Chen GL, et al. Among authors: ross ma. Biol Blood Marrow Transplant. 2018 Feb;24(2):373-380. doi: 10.1016/j.bbmt.2017.10.021. Epub 2017 Oct 16. Biol Blood Marrow Transplant. 2018. PMID: 29051021 Free PMC article. Clinical Trial.
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.
Chen GL, Hahn T, Wilding GE, Groman A, Hutson A, Zhang Y, Khan U, Liu H, Ross M, Bambach B, Higman M, Neppalli V, Sait S, Block AW, Wallace PK, Singh AK, McCarthy PL. Chen GL, et al. Among authors: ross m. Biol Blood Marrow Transplant. 2019 Apr;25(4):689-698. doi: 10.1016/j.bbmt.2018.09.042. Epub 2018 Oct 6. Biol Blood Marrow Transplant. 2019. PMID: 30300731 Free PMC article.
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
Weisdorf D, Cooley S, Wang T, Trachtenberg E, Vierra-Green C, Spellman S, Sees JA, Spahn A, Vogel J, Fehniger TA, Woolfrey AE, Devine SM, Ross M, Waller EK, Sobecks RM, McGuirk J, Oran B, Farag SS, Shore T, Van Besien K, Marsh SGE, Guethlein LA, Parham P, Miller JS. Weisdorf D, et al. Among authors: ross m. Blood Adv. 2020 Feb 25;4(4):740-754. doi: 10.1182/bloodadvances.2019001053. Blood Adv. 2020. PMID: 32092137 Free PMC article.
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell Transplantation.
Chen GL, Wallace PK, Zhang Y, Tario JD Jr, Przespolewski AC, Becker J, Almyroudis NG, Ross M, Riches M, Segal BH, Brix L, McCarthy PL, Hahn T. Chen GL, et al. Among authors: ross m. Biol Blood Marrow Transplant. 2020 Nov;26(11):2147-2154. doi: 10.1016/j.bbmt.2020.07.024. Epub 2020 Jul 25. Biol Blood Marrow Transplant. 2020. PMID: 32721522 Free PMC article.
BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.
Amro Elshoury, Wallace PK, Borowitz MJ, Kader A, Choi C, Ho C, Balderman S, Ross M, Hahn T, O'Neill V, McCarthy PL, Chen GL. Amro Elshoury, et al. Among authors: ross m. Bone Marrow Transplant. 2018 May;53(5):651-653. doi: 10.1038/s41409-017-0036-x. Epub 2018 Jan 17. Bone Marrow Transplant. 2018. PMID: 29343836 Free PMC article. No abstract available.
Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
Herr MM, Torka P, Zhang Y, Wallace PK, Tario JD Jr, Repasky EA, Chen GL, Ho CM, Balderman SR, Ross M, Paiva B, Hernandez-Ilizaliturri FJ, McCarthy PL, Hahn T. Herr MM, et al. Among authors: ross m. Bone Marrow Transplant. 2020 Jan;55(1):77-85. doi: 10.1038/s41409-019-0591-4. Epub 2019 Jun 21. Bone Marrow Transplant. 2020. PMID: 31227776 Free PMC article.
4,470 results